{"wiki_id": "http://www.wikidata.org/entity/Q3296254", "itemLabel": "Mary Broadfoot Walker", "itemDescription": "British physician", "wikipedia_url": "https://en.wikipedia.org/wiki/Mary_Broadfoot_Walker", "wikipedia_page": {"main": "Mary Broadfoot Walker (17 April 1888 \u2013 13 September 1974) was a Scottish physician who first demonstrated the effectiveness of physostigmine in the treatment of the condition myasthenia gravis, a disease relating to muscle weakness. She was also the first to recognise the association between familial periodic paralysis and low blood potassium levels.", "link_mentions": {}}}